Unclaimed brand
Paratek Pharmaceuticals is committed to developing and delivering innovative treatments for serious infectious diseases. Learn about our products, pipeline, and mission.
Liking this brand profile? Share this page


Hex Code
Color name
RGB
HSL
CMYK
#0A3F82
Catalina Blue
10, 63, 130
214, 86, 27
92, 52, 0, 49
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#333333
Mine Shaft
51, 51, 51
0, 0, 20
0, 0, 0, 80
Paratek Pharmaceuticals is a brand that is driven by a deep passion for patients. They believe that the right drugs, combined with the right knowledge and the right people, have the power to transform everyday decisions into everyday triumphs. Paratek is dedicated to developing groundbreaking medical treatments and solutions for complex issues.
One of their notable products is NUZYRA®, an FDA-approved tetracycline-class antibiotic. NUZYRA® is specifically designed to address the significant unmet needs of adult patients with Community-Acquired Bacterial Pneumonia (CABP) and Acute Bacterial Skin and Skin Structure Infections (ABSSSI) caused by susceptible bacteria.
At Paratek, they pride themselves on being a team of disciplined innovators with proven capabilities in commercializing novel treatment options. Their employees are experienced, committed, and driven to build a company that saves lives. If you share their passion, they offer exciting career opportunities to join their team.
Paratek is also actively taking on the challenge of Antimicrobial Resistance (AMR), recognizing the deadly health threat it poses. They emphasize the importance of new technologies and antibacterial therapy in combating global pandemics and defeating superbugs.
With offices in King of Prussia and Boston, Paratek Pharmaceuticals is committed to making a difference in healthcare and saving lives.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
Tetracycline-class antibiotics
Antimicrobial resistance therapies
Chronic rhinosinusitis treatments
Specialty pharmaceuticals